|
Zangani Investor Community Week in Review: May 9, 2008 |
|
WEBCASTS ![]() Interview with Jason Gonzalez, Chief Executive Officer of Visual Management Systems Zangani Investor Community interviews Jason Gonzalez, Chief Executive Officer of Visual Management Systems (VMS). Jason discusses the company's recent acquisition of substantially all the assets of Intelligent Digital Systems, LLC., a leading enterprise surveillance software development company and manufacturer of the TechEye® Line of Network and Digital Video Recording Devices. Visual Management Systems, Inc. (OTCBB: VMSY) is a New Jersey Based Corporation that consolidates the operations of subsidiaries including Visual Management Systems, LLC and Visual Management Systems PDG, LLC. The VMS Companies focus on providing businesses with remote management systems for loss prevention, physical security, asset protection and management controls - on and off-site. (READ MORE) NEWS
Cleveland BioLabs Completes Recruitment for Phase II Hormone-Refractory Prostate Cancer Trial Cleveland BioLabs, Inc. (NasdaqGM:CBLI - News), announced today that it has fully enrolled its Phase II clinical trial of Curaxin CBLC102 in advanced, hormone-refractory (androgen independent) prostate cancer. This open label trial is evaluating the safety and efficacy of Curaxin CBLC102 for use in treating patients with hormone-refractory metastatic prostate cancer. Curaxins have multiple mechanisms of action, including simultaneous activation of p53 and inhibition of NF-kappaB, which are frequently deregulated in cancer. Compounds that target p53 or NF-kappaB independently have been validated as cancer therapies; however, Curaxins are the only compounds currently known to CBLI that simultaneously target both pathways. (READ MORE)
BLOGS ![]() StemCellPatents.com - Partnership The Zangani Investor Community is proud to announce our latest partnership with StemCellPatents.com, a free comprehensive index of the Stem Cell Patents IP Minefield. Never in the history of medicine has a concept offered so much potential as the stem cell revolution. Unfortunately, due to the nature of current day science, overspecialization has occurred, forming walls between disciplines and thus impeding progress. The internet, by allowing global, free access to information, is the perfect tool for overcoming intellectual and geographical differences so as to facilitate international synergism through free exchange of ideas. This website is dedicated to the complete dissemination of intellectual accomplishment in the area of stem cells. We hope the information provided, as well as the various forum formats, will serve as a tool for unleashing the infinite medical potential of stem cell therapeutics. (READ MORE)
VIDEOS Welcome to Nanotech Today at InTimeTV.com. Nanotech Today is hosted by Ogan Gurel, MD/MPhil and combines two 21st century technologies - internet TV and nanotech - to communicate globally advances and trends in Nanotechnology worldwide. This week's episode of Nanotech Today features Hooman Mohseni PhD, Assistant Professor of Electrical Engineering & Computer Sciences - Northwestern University (READ MORE) UPCOMING EVENTS
Pharma Finance 2008
The Zangani Investor CommunityTM is proud to present Pharma Finance 2008 scheduled for May 22-23, 2008 (Thursday and Friday), in Roma, Italy. Pharma Finance 2008 features Investment Funds, Multinational/European Pharma Companies, as well as multiple Research Centers participating in the Conference, to offer a three-dimensional view of the European markets and further enhance our presenting companies' attendance. Additionally, specific round tables will be conducted in order to explore medical, scientific, and business opportunities for all the participants of the meeting. Pharma Finance 2008 is scheduled to be our largest event to date, designed to support in-depth partnership and collaboration development with 24 presenting groups. (READ MORE) |
|
|
© 2008 Zangani Investor Community, Unsubscribe from this newsletter. "Investor Community" is a Registered Trademark of L.G. Zangani LLC |